BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Timothy Ray Brown, First Patient to Be Cured of HIV, Dies of Leukemia

  Timothy Ray Brown, dubbed the “Berlin Patient,” the first ever to be cured of HIV, died from cancer on September 29.

  October 1, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Lifts Clinical Hold on Solid Biosciences’ DMD Gene Therapy Trial

  The trial was initially placed on hold in November 2019 due to safety concerns.

  October 1, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  What to Consider When Choosing References for a Job

  Whose contact information do you provide? What if they ask for multiple people? Below we answer common questions when it comes to selecting references for a job.

  October 1, 2020

   · 

  2 min read

   · 

  Laura Brothers
• 

  Business

  BioSpace Movers & Shakers, Oct. 2

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  October 1, 2020

   · 

  8 min read

   · 

  Alex Keown
• 

  BioCapital

  Research Roundup: Anti-Bacterial Immune Activation in COVID-19 and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  October 1, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Grants Fast Track Designation to Pfizer’s DMD Gene Therapy

  PF-06939926 is currently being evaluated to determine the safety and efficacy of this gene therapy in boys with DMD.

  October 1, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  FDA Deepens Safety Investigation of AstraZeneca’s Investigational COVID-19 Vaccine

  AstraZeneca’s Phase III COVID-19 vaccine study in the United States is being further delayed due to the U.S. FDA wanting to take a more thorough look at information related to the trial.

  October 1, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Alnylam Posts Positive Results of Groundbreaking Phase III PH1 Trial

  Alnilam – the bright center star in the middle of Orion’s belt – has navigated its namesake Alnylam to positive results in their ILLUMINATE-B Phase III clinical trial evaluating RNAi therapeutic, lumasiran, in young children with Primary hyperoxaluria Type 1 (PH1).

  October 1, 2020

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Business

  $21 Million Investment Expands Aphena’s Bottling, Cold Chain Storage Capabilities

  The expansion is part of the company’s acquisition of a 500,000-square-foot property that Aphena will renovate “into a state-of-the-art pharmaceutical and packaging and distribution facility.”

  October 1, 2020

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  After NASH Failures, Genfit Restructures and Cuts Staff by 40%

  As part of its half-year 2020 financial report, the company announced significant restructuring that will include cutting 40% of its staff.

  October 1, 2020

   · 

  2 min read

   · 

  Mark Terry